Skip to content

Author

Zai-Xiang Tang

We have 2 of 53 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

Sitagliptin for Acute Graft-Versus-Host Disease Prevention in Alternative Donor Transplantation: A Randomized Phase III Trial.

PURPOSE This trial evaluated whether the addition of sitagliptin to antithymocyte globulin (ATG)-based prophylaxis reduces the incidence of acute graft-versus-host disease (aGVHD) after alternative donor hematopoietic stem-cell transplantation. METHODS This prospective, multicenter, open-label, randomized trial enrol...

Man Qiao, Bi-Qi Zhou, Yi-Yin Chen et al. · 0 citations
Open access Aug 2026

Integrating single-cell transcriptomics and network pharmacology identifies ADORA1 as a candidate receptor for gastrodin derivatives in lung adenocarcinoma.

These analyses nominate ADORA1 as a candidate receptor and Gastrodin_T9 as a lead among gastrodin derivatives in LUAD; both candidates warrant mechanistic validation in LUAD-specific models.

L. Ao, Ting-You Zhang, Zan Li et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.